The relatively new GLP-1 medication retatrutide presents a considerable challenge regarding its cost. Presently, the list price hovers around approximately $1,400 for each dose, rendering it prohibitively expensive for many individuals. Considerations driving this high valuation include the intricate creation process, continued studies , and the sm